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The mos protooncogene ncodes a serine/threonine protein kinase that is only expressed at significant levels in germ cells. Recombinant muZE-mos 
protein (Xenopas mos protooncogene fused in frame to the maltose binding protein of E. coli) activates MAP kinase in cell-free extracts prepared 
from Xenopus oocytes and eggs. Here we show that malE-mos immunoprecipitates from Xenopus extracts phosphorylate and activate MAP kiiase 
kinase in vitro, indicating that MOS can function as a MAP kinase kinase kinase. Moreover, ectopic expression of mos in mammalian somatic cells, 
that lack any endogenous mos protein, triggers the activation of MAP kinase in vivo. These results identify the mos protooncogene as a direct 
activator of the MAP kinase pathway, with the potential to activate this kinase cascade ven in cells where normally there is no expression of mos. 
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1. INTRODUCTION 
Mitogen activated protein (MAP) kinases comprise 
a family of serine/threonine protein kinases conserved 
through evolution in all eukaryotic cells from yeast to 
humans, that participate in signal transduction path- 
ways initiated by many extracellular stimuli [14]. The 
activation of MAP kinases requires concomitant phos- 
phorylation on specific threonine and tyrosine residues 
[5,6], catalysed by a dual specificity MAP kinase kinase 
[7-91. MAP kinase kinase is in turn activated by serinel 
threonine phosphorylation [lo], catalysed by MAP ki- 
nase kinase kinases [ll-151. While the MAP kinase ki- 
nases identified so far are quite similar in structure and 
properties [16], there is more divergence at the level of 
MAP kinase kinase kinases, suggesting that the protein 
kinase cascade may integrate several different inputs at 
this point [ 151. 
MAP kinase is activated during the meiotic matura- 
tion of Xenopus oocytes induced by progesterone [17- 
191. We and others recently found that the mos protoon- 
cogene, a serinejthreonine protein kinase that is only 
expressed at high levels in germ cells and whose synthe- 
sis is required for progesterone-induced Xenopus oocyte 
maturation [20], can activate MAP kinase in Xenopus 
cell-free extracts [21] and intact oocytes [22]. Here we 
report that mos immunoprecipitates from Xenopus cell- 
free extracts can directly phosphorylate and activate 
MAP kinase kinase in vitro. In addition we show that 
expression of Xenopus mos in mammalian somatic cells 
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(NIH 3T3 fibroblasts) can activate the MAP kinase 
pathway. 
2. MATERIALS AND METHODS 
2.1. Preparation of active malE-mos protein 
Recombinant malE-mos fusion protein was purified from E. coli as 
described [21], and was activated by incubation in interphase Xenopus 
cell-free extracts. Interphase xtracts were prepared by treating CSF- 
arrested egg extracts [23] with 0.4 mM CaCl, for 60 min at 24’C, 
followed by 0.4 mM EGTA for 5 min. Typically, 1 pg of purified 
m&E-mos was incubated in 20 ~1 of interphase xtract for 50-60 min 
at 24°C. The extract was diluted IO-fold with ice-cold HI kinase buffer 
(80 mM B-glycerophosphate, 15 mM MgCl,, 20 mM EGTA) and 
activated malE-mos was immunoprecipitated by incubation with 3 ~1 
of anti-mu/E antibody (New England Biolabs) for 3 h on ice. The 
immunoprecipitates were recovered by incubation with protein A for 
30 min at 4°C and then washed 3 times with a buffer containing 20 
mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% Tween and protease 
inhibitors (1 mM PMSF, 2 mM benzamidine, IO&ml leupeptin and 
10 &ml aprotinin). 
2.2. Phosphorylation of MAP kinase kinase by mos in vitro 
Purified MAP kinase kinase from rabbit skeletal muscle [24] was 
inactivated by treatment with 30 mU of protein phosphatase 2A per 
ml for 30 min at 30°C. The phosphatase was then inhibited with 3pM 
okadaic acid. For the kinase reaction, mu/E-mos immunoprecipitates 
were washed once in 50 mM Tris-HCl, pH 7.5,O. 1 mM EGTA, 0.1% 
2-mercaptoethanol, 0.04% Brij-35, and then incubated for 30 min at 
30°C with 150 ng of the inactivated MAP kinase kinase, 10 mM 
magnesium acetate and 200 PM [r-‘*P]ATP (lo6 cpm/nmol) in a total 
volume of 20 ~1. Phosphorylations were analysed by SDS-PAGE and 
autoradiography. 
2.3. Activation of MAP kinase kinase by mos in vitro 
MaZE-mos immunoprecipitates were washed once in 50 mM Tris- 
HCl, pH 7.5,0.1 mM EGTA, 0.1% 2-mercaptoethanol, 0.04% Brij-35, 
and then incubated in a final volume of 40 ~1 with 200 PM ATP, 10 
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mM magnesium acetate, 1 PM inactive 42 kDa isofonn of MAP kinase 
(~42”‘“~‘) expressed in E. colt’ [25J, and either with or without inactive 
MAP kinase kinase isolated by MonoQ chromatography from unstim- 
ulated PC-12 cells [14]. In some experiments we used inactive MAP 
kinase kinase expressed in E. coli (S. Traverse et al., submitted). After 
30 min at 3O”C, 10 ~1 of the reaction supematant, was diluted 5-fold 
into ice-cold 50 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, 0.1% Z- 
mer~apt~~anol, 0.5 mM Na,V&, 1 mg/ml BSA, and assayed for 
MAP kinase activity with myelin basic protein (MBP) substrate as 
described previously [IO]. 
2.4. Phosphorylation and transcriptional activation of Elk-l in mouse 
fbroblasts transfected with mos 
To express mos in mammalian somatic cells, a 1.2 kb EcoRI-XhoI 
DNA fragment containing the full-Lynch Xenopus mos protoonco- 
gene, was inserted between the EcoRI and XhoI sites of the 
MLVBplink expression vector [26]. The resulting plasmid MLV-Mos 
was transfected into NIH 3T3 mouse fibroblasts by the DEAE-dex- 
tran protocol as described previously [27]. To study the phosphoryla- 
tion of the Elk-l transcription factor, fibroblasts were cotransfected 
with MLV-Mos, MLV-RasVa”2 or a control plasmid MLVb128 1271 
and the plasmid NL.Elk, which encodes a fusion protein in which the 
LexA DNA binding domain replaces the Ets domain in Elk-l [27]. To 
study the effect of mos on Elk-l transcriptional activity, fibroblasts 
were cotransfected with MLV-Mos, MLVNlex.ElkC, in which the 
C-terminal region of Elk-l is fused to the entire LexA coding region, 
and the reporter plasmid (LEX OP),TKCAT [28]. Following trans- 
fection, cells were serum deprived for 40 h, and then extracts were 
prepared and either analysed by western blotting with anti-l..exA an- 
tiserum or assayed for CAT activity [27,28]. 
2.5. Activation of MAP kinase in mouse fibroblasts expressing mos 
For preparation of a cell line expressing the Xenopus mos protoon- 
cogene, NIH 3T3 cells were cotransfected with 10 ,ug of MLV-Mos 
and 1 pg of pMEXneo [29], using the calcium phosphate precipitation 
technique. As a control, another cell line was prepared by transfection 
with the vector ~LV-~plink and pMEXneo. Colonies of G418-resis- 
tant cells were isolated, grown in 10% serum and finally serum de- 
prived for 24 h before analysis. Cell extracts were prepared in 50 mM 
Tris-HCl (pH 8), 150 mM NaCl, 20 mM NaF, 5 mM EDTA, 5 mM 
EGTA, 1 mM NaJVO,, 1% NP-40 and the same protease inhibitors 
as described above. The phosphorylation state of ~42”“~~ and p44”‘apk 
was determined by immunoblotting with a commercial monocfonal 
antibody, as recommended by the supplier (Zymed). MBP kinase 
activity was assayed as described [21,30], using either total extracts or 
p42m+ immunoprecipitates prepared with the anti-p42m”pk antiserum 
122 [31]. 
3. RESULTS AND DISCUSSION 
We have previously demonstrated that activation of 
MAP kinase by mos in Xenopus cell-free extracts in- 
volves MAP kinase kinase activation [21]. We were 
therefore interested in determining whether mos could 
directly activate MAP kinase kinase. Recombinant 
mole-mos protein is inactive as purified from bacteria 
but can be activated (by an unknown mechanism) by 
incubation in cell-free extracts prepared from Xenopus 
oocytes and eggs. For the activation experiments, we 
used interphase xtracts to avoid the possibility of con- 
tamination with MPF (cyclin B/~34”~‘~) during the im- 
munoprecipitation. Active male-rn~s recovered from 
the extracts by immunoprecipitation with anti-malE an- 
tibodies showed autophosphorylation activity (Fig. 1, 
lane 3). The mos immunoprecipitates were able to phos- 
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Fig. 1. Phosphorylation of MAP kinase kinase by mos in vitro. Puri- 
fied inactive MAP kinase kinase (lane 1), malE-mos immunoprecipi- 
tates (lane 3) or both together (lane 2) were incubated in the presence 
of Mg/[y-32P]ATP and then analysed by SDS-PAGE and autoradi- 
ography. 
phorylate purified MAP kinase kinase that had been 
dephosphorylated by PP2A treatment (Fig. 1, lane 2). 
To determine whether the phosphorylation of MAP ki- 
nase kinase by mos was accompanied by activation, we 
incubated the mos immunoprecipitates with inactive 
MAP kinase kinase (from unstimulated PC-l 2 cells) and 
recombinant p42mapk, and then assayed the supernatant 
for MAP kinase activity. As a control, we prepared 
immunoprecipitates with the anti-malE antibody from 
untreated Xenopus extracts, or with a control antibody 
from the same mos-treated extracts. In such experi- 
ments, we typically observed an increase of 8%IO-fold in 
the MAP kinase activity of samples treated with mos 
immunoprecipitates compared with the controls (Fig. 2, 
compare lane 2 with lane 4). We obtained exactly the 
same results when the inactive MAP kinase kinase from 
mammalian cells was replaced in these assays by recom- 
binant MAP kinase kinase purified from bacteria (not 
shown). In the absence of any MAP kinase kinase, how- 
ever, the mos immunoprecipitates were unable to stimu- 
late the MBP kinase activity of recombinant ~42”“~~ 
(Fig. 2, lane 3), indicating that mos cannot act directly 
as a MAP kinase kinase. These results also indicate that 
the mos immunoprecipitates were not contaminated 
with detectable levels of active MAP kinase kinase from 
the Xenopus extracts. Finally, as expected for a process 
of activation that involves phosphorylation, EDTA 
abolished the activation of MAP kinase kinase by mos 
(Fig. 2, lane 5). 
These results show that mos immunoprecipitates can 
phosphorylate and activate MAP kinase kinase, sug- 
gesting that mos may work as a MAP kinase kinase 
kinase. This is probably the way recombinant mos trig- 
gers the activation of MAP kinase in Xe~o~~s cell-free 
extracts f21f. We cannot rule out the possibility that 
another protein kinase co-immunoprecipitating with 
mos is actually responsible for the direct phosphoryla- 
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Fig. 2. Activation of MAP kinase kinase by MOS in vitro. Recombinant 
p42rnWk was incubated with maZE-mos immunoprecipitates (Ip Mos) 
or immunoprecipitates prepared with a control antibody (Ip C) in the 
absence (lanes 1 and 3) or in the presence (lanes 2 and 4) of inactive 
MAP kinase kinase, and then assayed for its activity on MBP. As a 
control, EDTA was added during the incubation of malE-mos im- 
munoprecipitates with MAP kinase kinase (lane 5) or during the acti- 
vation of malE-mos (prior to the immunoprecipitation) in the Xenopus 
cell-free extract (lane 6, Ip Mos*). Lane 7, activation with MAP kinase 
kinase kinase isolated from PC-12 cells [14]. Each lane shows the 
average of two determinations (standard deviation < 5%). Similar 
results were obtained in three experiments. 
tion and activation of MAP kinase kinase. However, if 
this is the case, this protein kinase must be specifically 
associated with and activated by mos. In this regard, it 
is intriguing that mos has recently been reported to be 
required for the activation of Raf-1 (a MAP kinase 
kinase kinase [l l-131) during Xenopus oocyte matura- 
tion [32,33]. However, the effect of a dominant negative 
mutant of Raf-1 on mos-induced oocyte maturation 
[32], could be explained if mos and Raf-1 were inde- 
pendently activated by a common mechanism. A4os 
(and other agents that activate the MAP kinase path- 
way) induce a hyperphosphorylation of Raf-1, but 
whether this phosphorylation is required for activation 
of Raf-1 or occurs subsequent to activation is unclear. 
The mechanism by which the mos protein kinase itself 
is activated is unknown. When recombinant malE-mos 
is incubated in Xenopus extracts supplemented with 
EDTA, the corresponding mos immunoprecipitates can 
no longer activate MAP kinase kinase in vitro (Fig. 2, 
lane 6), and also lose their autophosphorylation activity 
(not shown). These results suggest that mos may be 
activated by phosphorylation. It is generally agreed that 
mos is phosphorylated on serine residues during Xen- 
opus oocyte maturation, but there are conflicting re- 
ports regarding the importance of phosphorylation for 
mos activity [34,35]. Moreover, there are indications 
that some MAP kinase kinase kinases might be acti- 
vated by non-covalent modifications [14]. We have 
found it difficult to analyse this possibility, because the 
activity of mos immunoprecipitates prepared from Xen- 
opus extracts was very labile, completely losing activity, 
for instance, after 6 min at 30°C. Inactivation was not 
prevented by addition of 1 ,uM okadaic acid, suggesting 
that the lost of activity was not due to dephosphoryla- 
tion. Interestingly, the mos immunoprecipitates could 
be re-activated by incubation again in the Xenopus cell- 
free extracts, ruling out proteolysis of mos as an expla- 
nation for the instability. The activation of bacterially 
produced malE-mos was not restricted to Xenopus cell- 
free extracts. We have observed activation of malE-mos 
in extracts prepared from PC-12 cells (not shown) and 
another group has recently shown activation of a simi- 
lar malE-mos fusion protein upon incubation in rabbit 
reticulocyte lysates 1221. In agreement with our results, 
the mos immunoprecipitates prepared from reticulocyte 
lysates could activate MAP kinase kinase in vitro [22]. 
Since the mos protein kinase is normally only ex- 
pressed at significant levels in germ cells [20], we 
thought it would be of interest to determine whether 
ectopic expression of mos in somatic cells could also 
activate the MAP kinase pathway in vivo. For this pur- 
pose, we used a novel assay based on the transcription 
factor Elk-l, which is rapidly phosphorylated at multi- 
ple sites in its C-terminal region in response to activa- 
tion of the MAP kinase pathway in fibroblasts [28]. 
Elk-l has been shown to be a substrate for MAP kinase 
in vitro, and is phosphorylated by a 42 kDa kinase 
present in extracts from stimulated cells, which may be 
~42 mapk [28]. Cells were cotransfected with a plasmid 
expressing Xenopus mos and a LexA/Elk-1 fusion pro- 
tein. As shown in Fig. 3, expression of mos in NIH 3T3 
mouse fibroblasts induced the typical retardation in the 
f NL.ELk 
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Fig. 3. Phosphorylation of Elk-l in NIH 3T3 fibroblasts transfected 
with mos. Cell extracts were prepared from fibroblasts transfected 
with 3 pg of NL.Elk alone (lane 1) or cotransfected with the indicated 
amounts @g) of MLV-Mos (lanes 2-5), and analysed by western 
blotting with anti-LexA antiserum. Lanes 6 and 7, extracts prepared 
from NL.Elk-transfected fibroblasts stimulated for 15 min with 15% 
serum and from fibroblasts cotransfected with NL.Elk and MLV- 
Ras”“, respectively. Lane 8, extracts prepared from mock-trans- 
fected fibroblasts. 
185 
Volume 333, number 122 FEBS LETTERS CIctober 1993 
12345678 9 IO 
Fig, 4, Activzdion of Elk-l in NIH 3T3 fibroblasts transfected with 
mob. Cells were cotransfected with the indicated amounts (& of 
MLV-Mas and 4Fg of the reporter plasmid (LEX OP),TK.CAT alone 
(lanes 1-5) or together with 0.25 pg of plasrnid NLex.ElkC (lanes 
6-H& and then CAT activity was measured. Lanes 5 and 10, fibro- 
blasts were stimulated for 8 h with 15% serum. 
electrophoretic mobility of LexAfEik- 1 that accompa- 
nies the hy~~hos~~~~~ation f the Elk-l C-terminal 
region [27]. The activity of pnos in inducing Elk-l phos- 
phory~at~on is similar to that resulting from a 15 min 
serum stimulation (Fig. 3, iane 6) or ~onst~tut~v~ expres- 
sion of activated ras, a we&known activator of the 
MAP kinase pathway in mammalian fibroblasts [31] 
(Fig, 3, lane 7). Phaspho~iation of the Elk-l C-termirral 
region at the MAP kinase sites in response to serum 
induction of fibroblasts has previously been shown to 
stimulate its abihty to activate transcrip~on. Fig. 4 
shows that ~~~-induced phospho~l~ti~~ of Elk-l in 
serum deprived cells stimulated its transcriptional activ- 
ity to a similar degree. 
The phospho~~ation and a~t~va~on f Elk- 1 strongly 
suggests that mos is activating the MAP kinase pathway 
in ~b~~b~~sts. To obtain direct evidence for the activa- 
tion of MAP kinase, we prepared a fib~oblast-derived 
cell line expressing the Xeneplrs mos protooncogene. In 
this ceil line and in the absence of serum st~mu~atiou~ a 
s~g~~ca~t fraction of both p42=‘@ and p44-* show 
the lower eiectrophsretic mobility of the activated 
phosph~~lated forms (Fig. SA). To de~e~rni~e whether 
the phasphorylation of ~42”“~~ and p44m’ptpk correlated 
with their activation, we assayed the ability of these 
extracts to phospho~late MBff, an in vitro substrate of 
MAP kinases [30], As shown in Fig. $33, the total MBP 
kinase activity was &fold higher in extracts of mos- 
expressing cells than in control cells. This activation was 
more clearly apparent when we assayed the MBP kinase 
activity specifically associated with p42”‘“@ immunopre- 
cipitates, which showed a 4-S fold increase (Fig. SB). 
These results demonstrate that pylos can stimulate the 
MAP kirrase pathway in mouse fibroblasts, supporting 
our previous spe~~ati~~ [21] that activation of MAP 
kinase may be relevant not only for the function of the 
mos protooncogene in germ cells (such as ~e~~~~~ 
oocytes) but also for its transfo~ng activity in somatic 
cells. Although the precise contribution of MAP kinase 
activation to the process of cellular transformation by 
oncogenes remains unclear [%I, it is di~euIt to believe 
that inappropriate activation of such an important and 
highly conserved element of signal transduction path- 
ways is not connected to the transfo~at~o~ process. 
A B 
c, Mos 
c Mos c Mos 
Total p42mwk 
Fig, 5, Activation of MAP kinase in Flit 3T3 fibrobiasts expressing nlos. Cell extracts were prepared from a fibroblast-derived cell line expressing 
Xenopus m@s (Mos) or a control cell tine (C). (A) Western blotting with the monoclonal anti-MAP kin&se antibody. (Bf MBP kinase activity in 
total extracts and in ~$2~“~~ imm~opr~~p~tat~. Each lane shows the average of two determinations [standard deviation -z 3%). Similar results 
were obtained in two experiments. 
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